Home / Latest News / Online medicines sale: FDA orders FIR against Snapdeal CEO

Online medicines sale: FDA orders FIR against Snapdeal CEO

May,1,2015: Maharashtra’s Food and Drugs Administration (FDA) on Friday said it has ordered filing of FIR against e-commerce major Snapdeal.com’s CEO Kunal Bahl and directors of the company in a case related to alleged online sale of medicines, including prescription drugs.

Snapdeal.com co-founder & CEO Kunal Bahl
Snapdeal.com co-founder & CEO Kunal Bahl

FDA Commissioner Harshadeep Kamble told reporters here that filing of an FIR has been ordered against Mr. Bahl as well as directors of Snapdeal.

When contacted, the company spokesperson did not offer any immediate comment.

Last month, FDA had raided the company’s premises here in this regard. At that time, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

FDA had earlier issued a notice to the company and it was asked to furnish details of the drugs offered for sale, distribution and exhibited for sale on its website Snapdeal.com.

The raid followed FDA receiving information that various medicines, including prescription drugs, were being sold online through Snapdeal.com.

As per the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of a doctor, Mr. Kamble said, adding such type of online sale of drugs is not allowed as self medication can be harmful.


Facebook Comments

Check Also


Bitcoin in Trouble: Top Indian Banks suspend accounts of major Bitcoin Exchanges

January 20,2018: It has come to light that action has been initiated against at least top 10 Bitcoin exchanges including Zebpay, Unocoin, CoinSecure, and BtcxIndia. In a bid to crackdown on the dubious cryptocurrency transactions, top Indian banks have suspended ...

Leave a Reply

Your email address will not be published. Required fields are marked *